Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 1
1950 2
1951 1
1952 1
1953 2
1954 3
1956 1
1959 1
1961 1
1963 1
1966 1
1967 1
1971 3
1975 1
1977 6
1980 1
1982 2
1984 1
1985 1
1987 1
1989 1
1991 1
1992 1
1993 2
1995 1
1996 2
1997 2
1998 7
1999 4
2000 4
2001 3
2002 5
2003 5
2004 5
2005 5
2006 12
2007 7
2008 10
2009 14
2010 18
2011 23
2012 21
2013 35
2014 23
2015 20
2016 15
2017 14
2018 17
2019 13
2020 15
2021 18
2022 21
2023 20
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: guy l. Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024. Epub 2020 Aug 28. Eur Urol. 2021. PMID: 32868138 Clinical Trial.
First clinical-grade porcine kidney xenotransplant using a human decedent model.
Porrett PM, Orandi BJ, Kumar V, Houp J, Anderson D, Cozette Killian A, Hauptfeld-Dolejsek V, Martin DE, Macedon S, Budd N, Stegner KL, Dandro A, Kokkinaki M, Kuravi KV, Reed RD, Fatima H, Killian JT Jr, Baker G, Perry J, Wright ED, Cheung MD, Erman EN, Kraebber K, Gamblin T, Guy L, George JF, Ayares D, Locke JE. Porrett PM, et al. Among authors: guy l. Am J Transplant. 2022 Apr;22(4):1037-1053. doi: 10.1111/ajt.16930. Epub 2022 Jan 20. Am J Transplant. 2022. PMID: 35049121 Free article.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. Among authors: guy l. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Free article. Clinical Trial.
Persistent organic pollutants promote aggressiveness in prostate cancer.
Buñay J, Kossai M, Damon-Soubeyrant C, De Haze A, Saru JP, Trousson A, de Joussineau C, Bouchareb E, Kocer A, Vialat M, Dallel S, Degoul F, Bost F, Clavel S, Penault-Llorca F, Valli MP, Guy L, Matthews J, Renaud Y, Ittmann M, Jones J, Morel L, Lobaccaro JM, Baron S. Buñay J, et al. Among authors: guy l. Oncogene. 2023 Sep;42(38):2854-2867. doi: 10.1038/s41388-023-02788-2. Epub 2023 Aug 17. Oncogene. 2023. PMID: 37587334
[Circumcision and HIV].
Vardi A, Guy L, Boiteux JP. Vardi A, et al. Among authors: guy l. Prog Urol. 2008 Jun;18(6):331-6. doi: 10.1016/j.purol.2008.03.017. Epub 2008 May 8. Prog Urol. 2008. PMID: 18558320 Review. French.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
Special issue: Chirality in France.
Guy L, Oda R, Avarvari N, Crassous J, Berova N, Pescitelli G, Trapp O, Collina S. Guy L, et al. Chirality. 2022 May;34(5):697-698. doi: 10.1002/chir.23432. Epub 2022 Mar 3. Chirality. 2022. PMID: 35238416 No abstract available.
TADA: taxonomy-aware dataset aggregator.
Hägglund E, Andersson SGE, Guy L. Hägglund E, et al. Among authors: guy l. Bioinformatics. 2023 Dec 1;39(12):btad742. doi: 10.1093/bioinformatics/btad742. Bioinformatics. 2023. PMID: 38060257 Free PMC article.
372 results